search
Back to results

Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel

Primary Purpose

Intrauterine Adhesions, Septate Uterus

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hysteroscopic metroplasty
Autocross-linked acid hyaluronic gel
Office second look hysteroscopy
Sponsored by
University of Cagliari
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Intrauterine Adhesions

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • uterine septum
  • history of ≥1 miscarriage or infertility;
  • desire to have children in the future

Exclusion Criteria:

  • pregnancy;
  • menopause;
  • precancerous state or malignancy of the reproductive organs;
  • benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)
  • lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography;
  • withdrawal of patient consent;
  • rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ;
  • presence of external intercornual cleft;
  • incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively
  • excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    hysteroscopic metroplasty

    Arm Description

    women undergoing hysteroscopic metroplasty for uterine septum resection

    Outcomes

    Primary Outcome Measures

    Change in Formation of intrauterine adhesions

    Secondary Outcome Measures

    Full Information

    First Posted
    March 26, 2015
    Last Updated
    March 8, 2016
    Sponsor
    University of Cagliari
    Collaborators
    Università degli Studi di Sassari, Azienda Sanitaria Locale di Cagliari, Azienda Sanitaria Locale di Olbia, Azienda Sanitaria Locale di Oristano
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02404454
    Brief Title
    Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    June 2016 (undefined)
    Primary Completion Date
    December 2016 (Anticipated)
    Study Completion Date
    March 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Cagliari
    Collaborators
    Università degli Studi di Sassari, Azienda Sanitaria Locale di Cagliari, Azienda Sanitaria Locale di Olbia, Azienda Sanitaria Locale di Oristano

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The septate uterus is the most common structural uterine anomaly. It results from failure of the partition between the two fused Müllerian ducts to resorb;it is associated with the highest incidence of reproductive failure and with first- and second-trimester pregnancy loss and infertility. Hysteroscopic division of the uterine septum is performed using microscissors, electrosurgery, or laser. Several studies shown significant improvement in pregnancy outcome after hysteroscopic metroplasty. Purpose of this study is to verify the effectiveness of 5 ml, instead of 10 ml, of autocross-linked hyaluronic acid gel in the prevention of the formation of intrauterine adhesions, through second look office hysteroscopy after three months.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Intrauterine Adhesions, Septate Uterus

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    hysteroscopic metroplasty
    Arm Type
    Experimental
    Arm Description
    women undergoing hysteroscopic metroplasty for uterine septum resection
    Intervention Type
    Procedure
    Intervention Name(s)
    Hysteroscopic metroplasty
    Intervention Type
    Device
    Intervention Name(s)
    Autocross-linked acid hyaluronic gel
    Intervention Description
    Patients received adhesion barrier with 5 ml of autocross-linked acid hyaluronic gel
    Intervention Type
    Procedure
    Intervention Name(s)
    Office second look hysteroscopy
    Intervention Description
    Second-look hysteroscopy after three months
    Primary Outcome Measure Information:
    Title
    Change in Formation of intrauterine adhesions
    Time Frame
    baseline (operative isteroscopy and three months

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    45 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: uterine septum history of ≥1 miscarriage or infertility; desire to have children in the future Exclusion Criteria: pregnancy; menopause; precancerous state or malignancy of the reproductive organs; benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis) lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography; withdrawal of patient consent; rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ; presence of external intercornual cleft; incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)

    12. IPD Sharing Statement

    Learn more about this trial

    Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel

    We'll reach out to this number within 24 hrs